Angela Schmidt

Angela received her Bachelor of Nursing from the Queensland University of Technology in 2000. Over the years, she has used her expertise in nursing to take part in clinical research projects, and in clinical trials. She is currently overseeing the Phase 2 trial being led by the Ngo Group, testing the safety and tolerability of Trimetazidine in patients with MND.